The launch of BIRSA 101 marks a major breakthrough in CRISPR gene-editing technology, positioning India to deliver affordable ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the ...

After releasing two gene-edited rice varieties in May this year, scientists are now focusing on developing GE varieties of ...

Identifying the cause of fish kills can be challenging, but a WA researcher is using bivalves as spies to provide early intel ...

A team of researchers have developed a next-generation biological biosensor capable of detecting trace amounts of explosive ...

Artificial intelligence (AI) is fundamentally reshaping biotechnology and healthcare, unlocking the secrets hidden within ...

YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Tuesday, November 25, 2025 ...

CSIR to drive India’s five key securities through indigenous technology: DG Dr. Kalaiselvi in Jamshedpur | Jamshedpur News | ...

As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...

America's next wave of scientific talent may come from Lambert High School, where students used CRISPR to develop a promising ...

On Nov. 25, Wood’s Ark funds bought 174,293 Alphabet (GOOG) Class C stock, valued at approximately $55.77 million. On the day ...